Results 11 to 20 of about 31,946 (224)
Changing Pattern of Visceral Leishmaniasis, United Kingdom, 1985-2004 [PDF]
A 20-year (1985–2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed.
Aeesha N.J. Malik +3 more
doaj +7 more sources
Visceral leishmaniasis in Afghanistan [PDF]
Despite being the third most important vector-borne diseases worldwide in terms of burden of disease, the leishmaniases are one of the so-called “neglected diseases.” Since the massive humanitarian re-construction efforts began after the fall of the Taliban in 2002, Afghanistan is ...
Toby, Leslie +8 more
openaire +4 more sources
Bayesian geostatistical modeling of leishmaniasis incidence in Brazil. [PDF]
BackgroundLeishmaniasis is endemic in 98 countries with an estimated 350 million people at risk and approximately 2 million cases annually. Brazil is one of the most severely affected countries.MethodologyWe applied Bayesian geostatistical negative ...
Dimitrios-Alexios Karagiannis-Voules +4 more
doaj +3 more sources
Visceral leishmaniasis (VL) is a vector-borne parasitic disease targeting tissue macrophages. It is among the most neglected infectious diseases. Classical manifestations of VL include chronic fever, hepatosplenomegaly, and pancytopenia. Most cases can be detected through serologic and molecular testing.
van Griensven, J., Diro, E.
+6 more sources
Immunity to Visceral Leishmaniasis [PDF]
Peer ...
Ali, Nahid Ben +3 more
openaire +6 more sources
Oral miltefosine for Indian visceral leishmaniasis. [PDF]
BACKGROUND: There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost all untreated patients die, and all the effective agents have been parenteral.
Berman, Jonathan +10 more
core +1 more source
Visceral leishmaniasis in eastern Africa--current status. [PDF]
Visceral leishmaniasis (VL) is among the most neglected of the tropical diseases, afflicting the poorest of the poor. In eastern Africa, VL causes at least 4000 deaths annually, a loss of approximately 385,000 disability-adjusted life years.
Reithinger, Richard +3 more
core +1 more source
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial [PDF]
Alternative treatments for visceral leishmaniasis (VL) are required in East Africa.
Makonnen, Eyasu +151 more
core +2 more sources
ANÁLISE DOS FATORES QUE INFLUENCIAM A OCORRÊNCIA DA LEISHMANIOSE VISCERAL HUMANA
Objective: to analyze the factors that influence the occurrence of Human Visceral Leishmaniasis in the state of Paraíba, Brazil. Methods: ecological study, developed with data from 2012 to 2017, collected in a reference laboratory in the state and in the
Allan Batista Silva +5 more
doaj +1 more source
Background There is paucity of data on quality of life as a dimension of treatment outcome among Visceral Leishmaniasis and HIV coinfected patients. This study sought to explore perceived quality of life among Visceral Leishmaniasis and HIV coinfected ...
Mekuriaw Alemayehu +3 more
doaj +1 more source

